Trial intelligence / Profile preview

Capmatinib in MET exon 14 skipping-mutant NSCLC (Phase II, Korea)

KCT0002980Phase 2Not yet recruiting

Sponsor

Asan Medical Center

Start

Dec 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1